Andrew D.c. LaFrence - 20 May 2021 Form 4 Insider Report for Vyant Bio, Inc.

Role
Chief Financial Officer
Signature
/s/ Andrew LaFrence
Issuer symbol
N/A
Transactions as of
20 May 2021
Net transactions value
+$9,837
Form type
4
Filing time
21 May 2021, 16:05:24 UTC
Previous filing
13 Jul 2021
Next filing
29 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Purchase $9,837 +3,000 +10% $3.28 32,336 20 May 2021 Direct
holding VYNT Common Stock, $0.0001 par value 26,866 20 May 2021 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.